PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
40.25%
Net income growth above 1.5x MRVL's 16.19%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-0.97%
Negative yoy D&A while MRVL is 1.92%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-54.05%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-1.28%
Negative yoy SBC while MRVL is 22.61%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
34.11%
Slight usage while MRVL is negative at -32.93%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-10.74%
Both yoy AR lines negative, with MRVL at -50.89%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-276.47%
Both reduce yoy inventory, with MRVL at -218.89%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
49.57%
AP growth well above MRVL's 89.84%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
99.28%
Lower 'other working capital' growth vs. MRVL's 256.27%. David Dodd would see fewer unexpected short-term demands on cash.
81.82%
Some yoy increase while MRVL is negative at -28.02%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
67.75%
Operating cash flow growth above 1.5x MRVL's 3.15%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-3.90%
Negative yoy CapEx while MRVL is 20.08%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
60.51%
Purchases well above MRVL's 46.35%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
64.84%
We have some liquidation growth while MRVL is negative at -51.48%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-302.63%
Both yoy lines negative, with MRVL at -118.30%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
362.95%
We have mild expansions while MRVL is negative at -5349.55%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-100.80%
We cut debt repayment yoy while MRVL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-55.83%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-3.19%
We cut yoy buybacks while MRVL is 59.34%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.